L02BG Aromatase inhibitors

PheWeb

RX_L02BG

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Medicine purchases: ATC L02BG

8470

Check pre-conditions, main-only, mode, ICD version None

5831

Check minimum number of events

Min. number of events 3

5831

Include endpoints None

5831

RX_L02BG

Extra metadata

First used in FinnGen datafreeze DF3

Similar endpoints

↥

List of similar endpoints to L02BG Aromatase inhibitors based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	5656	5606	50
Unadjusted prevalence (%)	1.83	3.23	0.04
Mean age at first event (years)	63.38	63.55	43.78

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.08	6.40 [4.56, 8.98]	6.6e-27	417
15 years	0.02	2.64 [1.85, 3.79]	1.2e-7	167
5 years	0.01	7.72 [5.42, 11.01]	1.3e-29	225
1 year	0.00	3.54 [2.09, 6.00]	2.7e-6	21

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: RX_L02BG – L02BG Aromatase inhibitors
GWS hits:

Survival analyses between endpoints

↥

Plot

before L02BG Aromatase inhibitors
after L02BG Aromatase inhibitors

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after L02BG Aromatase inhibitors

↥